Risk for stroke after elective noncarotid vascular surgery.

INTRODUCTION Patients undergoing operations to treat peripheral vascular disease have systemic atherosclerosis and are at risk for stroke. However, the incidence and effect of cerebrovascular events on noncarotid vascular surgical outcomes are not well-defined. METHODS Patients undergoing common operations for vascular disease from 1997 to 2000 were examined with data from the Veterans Affairs (VA) National Surgery Quality Improvement Project and the VA patient treatment files. Operations studied included abdominal aortic aneurysmectomy (n = 2551), aortobifemoral bypass (n = 2616), lower extremity bypass (n = 6866), and major lower extremity amputation (n = 7442). The incidence of perioperative stroke was determined, and logistic regression analysis was used to identify independent risk factors for stroke. Logistic and linear regression analyses were used to quantify the effect of postoperative stroke on adjusted mortality and length of stay. Odds ratio (OR) and 95% confidence interval (CI) were defined. P <.05 was considered significant. RESULTS Stroke was uncommon after noncarotid vascular procedures, occurring in only 0.4% to 0.6% of patients. Independent risk factors for stroke include preoperative ventilation (OR, 11; 95% CI, 5.0-22.3; P <.001), previous stroke or transient ischemic attack (OR, 4.2; 95% CI, 2.7-6.4; P <.001), postoperative myocardial infarction (OR, 3.3; 95% CI, 1.3-8.7; P =.009), and need to return to the operating room (OR, 2.2; 95% CI, 1.4-3.5; P =.001). Factors that did not appear to be associated with stroke risk included procedure type, diabetes, renal failure, dialysis dependence, number of transfused units of blood, and hypertension. After controlling for other postoperative complications and comorbid conditions, postoperative stroke significantly increased the risk for perioperative mortality (OR, 6.3; 95% CI, 3.4-11.4; P <.001), with similar magnitude as postoperative myocardial infarction (OR, 6.3; 95% CI, 3.9-10.1; P <.001). Stroke was also associated with a 48% increase in overall length of stay. CONCLUSIONS Stroke after noncarotid peripheral vascular surgery is uncommon, but results in markedly increased mortality and length of stay. Stroke risk is most strongly associated with previous stroke history and greater degree of illness. Patients with these associated conditions deserve particular attention to assessing and medically managing modifiable risk factors.

[1]  W. Henderson,et al.  The National Surgical Quality Improvement Program in Non-Veterans Administration Hospitals: Initial Demonstration of Feasibility , 2002, Annals of surgery.

[2]  K. Johnston,et al.  Multicenter prospective study of nonruptured abdominal aortic aneurysms. I. Population and operative management. , 1988, Journal of vascular surgery.

[3]  David Colquhoun,et al.  Pravastatin Therapy and the Risk of Stroke , 2000 .

[4]  L. Greenfield,et al.  Cost of routine screening for carotid and lower extremity occlusive disease in patients with abdominal aortic aneurysms. , 2002, Journal of vascular surgery.

[5]  R. Bell,et al.  Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program. , 1999, Annals of surgery.

[6]  Jeroen J. Bax,et al.  The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery , 2000 .

[7]  H. Lau,et al.  Prevalence of significant carotid stenosis in Chinese patients with peripheral and coronary artery disease. , 1999, The Australian and New Zealand journal of surgery.

[8]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[9]  D. Mangano.  Aspirin and mortality from coronary bypass surgery. , 2002, The New England journal of medicine.

[10]  Neurologic deficits following noncarotid vascular surgery. , 1992, American journal of surgery.

[11]  C. Patrono.  Aspirin as an antiplatelet drug. , 1994, The New England journal of medicine.

[12]  J. Dormandy,et al.  Lower-extremity arteriosclerosis as a reflection of a systemic process: implications for concomitant coronary and carotid disease. , 1999, Seminars in vascular surgery.

[13]  V. Gahtan,et al.  Gender does not impact infrainguinal vein bypass graft outcome. , 2000, Surgery.

[14]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .

[15]  S. Kerdi,et al.  Infrarenal Abdominal Aortic Aneurysm Repair: Detection and Treatment of Associated Carotid and Coronary Lesions , 1997, Annals of vascular surgery.

[16]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[17]  H. White,et al.  Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes , 2002, Circulation.

[18]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[19]  V. Fuster,et al.  AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 2001, Circulation.

[20]  M. Dennis.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[21]  V. Fuster,et al.  AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 2001, Journal of the American College of Cardiology.

[22]  B. Davis,et al.  Reduction of Stroke Events With Pravastatin: The Prospective Pravastatin Pooling (PPP) Project , 2001, Circulation.

[23]  Jeroen J. Bax,et al.  The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.

[24]  E. Antman,et al.  ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat , 2002, Circulation.

[25]  F. Grover,et al.  The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. , 1998, Annals of surgery.

[26]  R. Erbel,et al.  Preprocedural Statin Medication Reduces the Extent of Periprocedural Non–Q-Wave Myocardial Infarction , 2002, Circulation.

[27]  T. Cogbill,et al.  Perioperative stroke risk in 173 consecutive patients with a past history of stroke. , 1990, Archives of surgery.

[28]  J. Eidt,et al.  Abdominal Aortic Aneurysm Repair , 2001, Vascular surgery.

[29]  R. J. Valentine,et al.  Asymptomatic carotid stenosis and unrelated operations: should we be more aggressive? , 2001, Journal of the American College of Surgeons.